v3.25.3
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows used in operating activities:    
Net loss $ (11,456,282) $ (6,651,198)
Stock based compensation 864,031 932,558
Amortization of intangibles 75,000 75,000
Realized and unrealized gain and accrued interest on investments (138,811) (186,512)
Changes in assets and liabilities:    
Increase (decrease) in accounts payable and accrued expenses 1,583,619 (107,741)
Decrease in prepaid expenses and other assets 566,474 317,103
Net cash used in operating activities (8,505,969) (5,620,790)
Cash flows provided by investing activities:    
Purchase of investments   (11,255,963)
Proceeds from redemption of investments 6,990,574 12,546,000
Net cash provided by investing activities 6,990,574 1,290,037
Cash flows (used in) provided by financing activities:    
Payment of amounts due to officers (450,000) (450,000)
Proceeds from sale of equity securities, net 172,958 5,496,305
Net cash (used in) provided by financing activities (277,042) 5,046,305
Net change in cash and cash equivalents: (1,792,437) 715,552
Cash and cash equivalents - beginning of period 3,623,343 2,401,198
Cash and cash equivalents - end of period $ 1,830,906 3,116,750
Supplemental information - Non cash items:    
Offering expenses associated with warrant modification   $ 209,225